These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22512910)

  • 1. Orf-induced pemphigoid with antilaminin-332 antibodies.
    van den Bos RR; Middelburg T; van Biezen P; van der Eijk AA; Pas HH; Diercks GF
    Br J Dermatol; 2012 Oct; 167(4):956-8. PubMed ID: 22512910
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemphigoid without mucosal involvement showing autoantibodies against laminin-332 γ2 subunit.
    Endo Y; Kato M; Kitoh A; Kore-Eda S; Fukuda S; Hashimoto T; Toda K; Miyachi Y; Utani A
    Br J Dermatol; 2010 Nov; 163(5):1120-2. PubMed ID: 20586779
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of antilaminin 332 mucous membrane pemphigoid showing a blister on the bulbar conjunctiva and a unique epitope on the alpha3 subunit.
    Hashimoto T; Dainichi T; Ohyama B; Hamada T; Ishii N; Sato N; Tanigawa O; Nakayama J; Amano S; Nishiyama T; Karashima T; Nakama T; Yasumoto S
    Br J Dermatol; 2010 Apr; 162(4):898-9. PubMed ID: 20199543
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemphigoid nodularis with diverse IgG, IgA and IgE antibodies showing neutrophilic papillary microabscesses.
    Asahina A; Niizuma A; Ohzono A; Ishii N; Koga H; Hashimoto T
    Acta Derm Venereol; 2015 Feb; 95(2):239-40. PubMed ID: 24854228
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-laminin 5 pemphigoid: a case report of a benign cutaneous confined non-cicatricial variant.
    Magro CM; Wu R
    Int J Dermatol; 2012 Jan; 51(1):79-85. PubMed ID: 21790553
    [No Abstract]   [Full Text] [Related]  

  • 8. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
    Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
    [No Abstract]   [Full Text] [Related]  

  • 9. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
    Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid with IgG anti-LAD-1 antibodies.
    Matsui K; Makino T; Takegami Y; Murayama S; Seki Y; Ishii N; Hashimoto T; Shimizu T
    Eur J Dermatol; 2014; 24(2):275-6. PubMed ID: 24751371
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous pemphigoid complicating human orf.
    Murphy JK; Ralfs IG
    Br J Dermatol; 1996 May; 134(5):929-30. PubMed ID: 8736338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: first report from India.
    Kanwar AJ; Vinay K; Koga H; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2012; 78(4):475-9. PubMed ID: 22772619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
    Yamauchi PS; Lowe NJ; Gindi V
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of concurrent antilaminin γ1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid.
    Li X; Qian H; Ishii N; Yamaya M; Fukuda H; Mukai H; Hirako Y; Hashimoto T
    Br J Dermatol; 2014 Nov; 171(5):1257-9. PubMed ID: 25262782
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human orf complicated by mucous membrane pemphigoid.
    van Lingen RG; Frank RG; Koopman RJ; Jonkman MF
    Clin Exp Dermatol; 2006 Sep; 31(5):711-2. PubMed ID: 16901317
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of mucous membrane pemphigoid characterized by circulating immunoglobulin A and immunoglobulin G autoantibodies to the gamma-2 subunit of laminin-332.
    Hanawa F; Harada K; Andou N; Kawamura T; Shibagaki N; Fukuda S; Hashimoto T; Shimada S
    J Dermatol; 2012 Nov; 39(11):962-3. PubMed ID: 22364356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.